» Articles » PMID: 5540178

Hormonal Regulation of Human Lower Esophageal Sphincter Competence: Interaction of Gastrin and Secretin

Overview
Journal J Clin Invest
Specialty General Medicine
Date 1971 Feb 1
PMID 5540178
Citations 56
Authors
Affiliations
Soon will be listed here.
Abstract

The interaction of gastrin and secretin, in the regulation of human lower esophageal sphincter competence, was studied in 54 normal subjects. A dose-response curve, for the lower esophageal sphincter, was constructed from the rapid intravenous injections of synthetic gastrin I (amino acid sequence 2-17). This curve was sigmoid shaped and showed a peak response that was 460.0 +/-24.0% (mean +/-2 SE) of the initial sphincter pressure, at a dose of 0.7 mug/kg of gastrin I. Secretin, either endogenously released by duodenal acidification, or exogenously administered as a single intravenous injection, markedly reduced the peak response of the sphincter to gastrin I. To ascertain the character of this inhibition, a gastrin I dose-response curve was obtained during a continuous intravenous secretin infusion. This curve showed a parallel shift to the right, with the maximal sphincter response to gastrin I still attainable at higher doses. A sphincter, endogenously stimulated by gastrin, showed a dose-related reduction in pressure with rapid intravenous injections of secretin. At the level of resting sphincter pressure, response to secretin diminished, and larger doses were required for comparable reduction in pressure. These studies indicate; (a) Secretin interacts with gastrin in the physiological regulation of human lower esophageal sphincter competence; (b) Secretin is a sensitive inhibitor to gastrin stimulation of the lower esophageal sphincter; (c) This inhibitory effect of secretin is competitive in character.

Citing Articles

Improvement of atropine on esophagogastric junction observation during sedative esophagogastroduodenoscopy.

Chen Z, Liu L, Tu J, Qin G, Su W, Geng X PLoS One. 2017; 12(6):e0179490.

PMID: 28654639 PMC: 5487030. DOI: 10.1371/journal.pone.0179490.


Gastrointestinal diseases: facts and fiction.

Jeejeebhoy K Can Fam Physician. 2010; 19(2):72-4.

PMID: 20468888 PMC: 2370825.


The effect of esophageal and gastric distension on the crural diaphragm.

Shafik A, Shafik I, El Sibai O, Mostafa R World J Surg. 2006; 30(2):199-204.

PMID: 16425081 DOI: 10.1007/s00268-005-0282-8.


Effect of straining on diaphragmatic crura with identification of the straining-crural reflex. The "reflex theory" in gastroesophageal competence.

Shafik A, Shafik A, El Sibai O, Mostafa R BMC Gastroenterol. 2004; 4:24.

PMID: 15458570 PMC: 538286. DOI: 10.1186/1471-230X-4-24.


The role of motilin and cisapride in the enteric nervous system of the lower esophageal sphincter in humans.

Tomita R, Tanjoh K, Munakata K Surg Today. 1997; 27(11):985-92.

PMID: 9413048 DOI: 10.1007/BF02385776.


References
1.
Winans C, Harris L . Quantitation of lower esophageal sphincter competence. Gastroenterology. 1967; 52(5):773-8. View

2.
Wormsley K, GROSSMAN M . INHIBITION OF GASTRIC ACID SECRETION BY SECRETIN AND BY ENDOGENOUS ACID IN THE DUODENUM. Gastroenterology. 1964; 47:72-81. View

3.
EMAS S, GROSSMAN M . Difference in responses between dogs and cats to large doses of gastrin on gastric secretion. Gut. 1967; 8(3):267-75. PMC: 1552471. DOI: 10.1136/gut.8.3.267. View

4.
Makhlouf G, MCMANUS J, Knill J . Quantitative aspects of synergism and inhibition of gastric acid secretion. Gastroenterology. 1968; 54(4):532-7. View

5.
VAGNE M, STENING G, BROOKS F, GROSSMAN M . Synthetic secretin: comparison with natural secretin for potency and spectrum of physiological actions. Gastroenterology. 1968; 55(2):260-7. View